A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

Background: Non-selective cyclooxygenase (COX) inhibitors (non-steroidal anti-inflammatory drugs) inhibit large bowel carcinogenesis in patients with familial adenomatous polyposis (FAP). Their role in the duodenum of these patients is less certain. The disease modifying activity of specific COX-2 i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Phillips, R K S, Wallace, M H, Lynch, P M, Hawk, E, Gordon, G B, Saunders, B P, Wakabayashi, N, Shen, Y, Zimmerman, S, Godio, L, Rodrigues-Bigas, M, Su, L-K, Sherman, J, Kelloff, G, Levin, B, Steinbach, G
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2002 by Gut 2002
Assuntos:
Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773237/
https://ncbi.nlm.nih.gov/pubmed/12010890
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
A carregar...

Registos relacionados